<?xml version="1.0" encoding="UTF-8"?>
<p id="par0315">Multiple other treatments are currently under investigation. The following are a few examples: Darunavir/cobicistat (HIV-1 protease inhibitor): Eculizumab (humanized monoclonal IgG antibody against complement protein C5); Favipiravir (RNA polymerase inhibitor); Nelfinavir (HIV-1 protease inhibitor); Sarilumab (IL-6 receptor antagonist); Sofosbuvir (Antiviral used to treat hepatitis C); TZLS-501 (anti-IL6R); Vitamin C; Siltuximab (Sylvant®; a chimeric mAb that targets IL-6); Xuebijing (XBJ), ribonucleoside analog β-D-N4-hydroxycytidine (NHC, EIDD-1931); zinc sulfate [
 <xref rid="bib0035" ref-type="bibr">7</xref>,
 <xref rid="bib0345" ref-type="bibr">69</xref>,
 <xref rid="bib0455" ref-type="bibr">[91]</xref>, 
 <xref rid="bib0460" ref-type="bibr">[92]</xref>, 
 <xref rid="bib0465" ref-type="bibr">[93]</xref>].
</p>
